1. Home
  2. GDTC vs OESX Comparison

GDTC vs OESX Comparison

Compare GDTC & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • OESX
  • Stock Information
  • Founded
  • GDTC 2018
  • OESX 1996
  • Country
  • GDTC Singapore
  • OESX United States
  • Employees
  • GDTC N/A
  • OESX N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • OESX Building Products
  • Sector
  • GDTC Health Care
  • OESX Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • OESX Nasdaq
  • Market Cap
  • GDTC 25.1M
  • OESX 27.5M
  • IPO Year
  • GDTC 2023
  • OESX 2007
  • Fundamental
  • Price
  • GDTC $2.17
  • OESX $0.88
  • Analyst Decision
  • GDTC Buy
  • OESX Strong Buy
  • Analyst Count
  • GDTC 1
  • OESX 1
  • Target Price
  • GDTC $5.00
  • OESX $3.00
  • AVG Volume (30 Days)
  • GDTC 22.4K
  • OESX 59.4K
  • Earning Date
  • GDTC 01-01-0001
  • OESX 11-06-2024
  • Dividend Yield
  • GDTC N/A
  • OESX N/A
  • EPS Growth
  • GDTC N/A
  • OESX N/A
  • EPS
  • GDTC N/A
  • OESX N/A
  • Revenue
  • GDTC $330,254.00
  • OESX $91,649,000.00
  • Revenue This Year
  • GDTC $14.71
  • OESX $13.74
  • Revenue Next Year
  • GDTC N/A
  • OESX $14.83
  • P/E Ratio
  • GDTC N/A
  • OESX N/A
  • Revenue Growth
  • GDTC N/A
  • OESX 14.40
  • 52 Week Low
  • GDTC $1.20
  • OESX $0.81
  • 52 Week High
  • GDTC $5.50
  • OESX $1.53
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 47.02
  • OESX 39.30
  • Support Level
  • GDTC $2.11
  • OESX $0.92
  • Resistance Level
  • GDTC $2.60
  • OESX $1.03
  • Average True Range (ATR)
  • GDTC 0.33
  • OESX 0.05
  • MACD
  • GDTC -0.07
  • OESX -0.02
  • Stochastic Oscillator
  • GDTC 34.42
  • OESX 15.06

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc is a developer, manufacturer, and seller of lighting and energy management systems. The company segments include Orion Lighting Segment, Orion Maintenance Segment and Orion Electric Vehicle Charging Segment. It derives maximum revenue from Lighting Segment.

Share on Social Networks: